PExA
0,21 SEK
-13,69 %
Mindre end 1K følgere
PEXA B
Spotlight Stock Market
Medical Equipment & Services
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
-13,69 %
-24,09 %
-20,61 %
-4,59 %
+30,00 %
+36,60 %
-56,23 %
-84,65 %
-90,05 %
PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.
Læs mereMarkedsværdi
25,82 mio. SEK
Aktieomsætning
5,31 t SEK
Omsætning
477,68 t
EBIT %
-1.322,21 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning mio.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
22.5
2026
Delårsrapport Q1'26
28.5
2026
Generalforsamling '26
28.8
2026
Delårsrapport Q2'26